Celldex Therapeutics Inc. (CLDX) Social Stream
CELLDEX THERAPEUTICS INC (CLDX) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering CLDX.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-02-14 | 5 | $68 | $60 | $64.833 | $31.18 | 107.93% |
| 2022-03-01 | 6 | $68 | $60 | $64.833 | $31.18 | 107.93% |
| 2022-05-06 | 6 | $68 | $59 | $64.5 | $31.18 | 106.86% |
| 2022-08-09 | 5 | $73 | $55 | $65.2 | $31.18 | 109.11% |
| 2022-10-10 | 5 | $73 | $55 | $64.6 | $31.18 | 107.18% |
| 2023-02-27 | 6 | $73 | $55 | $64.333 | $31.18 | 106.33% |
| 2023-05-05 | 6 | $73 | $54 | $64.833 | $31.18 | 107.93% |
The Trend in the Analyst Price Target
CLDX's average price target has moved up $38.5 over the prior 28 months.
Over the past 41 weeks, CLDX's average upside potential has been 75.54%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-07-21 | 5 | 73 | 59 | 66.800 | 30.85 | 116.53% |
| 2022-08-09 | 5 | 73 | 55 | 65.200 | 35.28 | 84.81% |
| 2022-11-14 | 6 | 73 | 55 | 64.333 | 36.50 | 76.25% |
| 2023-02-08 | 6 | 73 | 55 | 64.333 | 42.34 | 51.94% |
| 2023-02-27 | 6 | 73 | 55 | 64.333 | 43.05 | 49.44% |
CLDX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 6 | 0 | 0 | 0 | 0 | 6 |
The Trend in the Broker Recommendations
CLDX's average broker recommendation rating improved by 0.75 over the prior 20 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- CELLDEX THERAPEUTICS INC's variance in analysts' estimates is lower than -91.55% of all US stocks.
- CELLDEX THERAPEUTICS INC's average analyst price target is higher than 695.13% of Pharmaceutical Products stocks.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, CELLDEX THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 678.51% of them.
- CLDX has a greater number of analysts covering the stock than 262.74% of stocks in the mid market cap category.
In the Pharmaceutical Products industry, NEOG, EVO, and ZNTL are the three stocks most similar to CELLDEX THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is CLDX a Buy, Hold or Sell? See the POWR Ratings now!